JP2015083582A5 - - Google Patents

Download PDF

Info

Publication number
JP2015083582A5
JP2015083582A5 JP2014247793A JP2014247793A JP2015083582A5 JP 2015083582 A5 JP2015083582 A5 JP 2015083582A5 JP 2014247793 A JP2014247793 A JP 2014247793A JP 2014247793 A JP2014247793 A JP 2014247793A JP 2015083582 A5 JP2015083582 A5 JP 2015083582A5
Authority
JP
Japan
Prior art keywords
suspension
less
volume
suspension according
gauge needle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014247793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015083582A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015083582A publication Critical patent/JP2015083582A/ja
Publication of JP2015083582A5 publication Critical patent/JP2015083582A5/ja
Pending legal-status Critical Current

Links

JP2014247793A 2008-11-16 2014-12-08 高濃度の低粘度懸濁液 Pending JP2015083582A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11508008P 2008-11-16 2008-11-16
US61/115,080 2008-11-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011536414A Division JP5711138B2 (ja) 2008-11-16 2009-11-10 高濃度の低粘度懸濁液

Publications (2)

Publication Number Publication Date
JP2015083582A JP2015083582A (ja) 2015-04-30
JP2015083582A5 true JP2015083582A5 (OSRAM) 2015-07-02

Family

ID=42170660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011536414A Expired - Fee Related JP5711138B2 (ja) 2008-11-16 2009-11-10 高濃度の低粘度懸濁液
JP2014247793A Pending JP2015083582A (ja) 2008-11-16 2014-12-08 高濃度の低粘度懸濁液

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011536414A Expired - Fee Related JP5711138B2 (ja) 2008-11-16 2009-11-10 高濃度の低粘度懸濁液

Country Status (7)

Country Link
US (2) US8779094B2 (OSRAM)
EP (1) EP2376522A4 (OSRAM)
JP (2) JP5711138B2 (OSRAM)
KR (1) KR20110103961A (OSRAM)
CA (1) CA2743789C (OSRAM)
IL (1) IL212919A (OSRAM)
WO (1) WO2010056657A2 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) * 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
CA2792517C (en) * 2010-03-09 2020-03-24 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations
US9445990B2 (en) * 2010-10-06 2016-09-20 Medtronic, Inc. TNF inhibitor formulation for use in implantable infusion devices
WO2012122544A2 (en) * 2011-03-10 2012-09-13 Board Of Regents, The University Of Texas System Protein nanoparticle dispersions
WO2013063510A1 (en) * 2011-10-28 2013-05-02 Integritybio Inc. Protein formulations containing amino acids
EP3854433A3 (en) 2011-11-07 2021-10-27 Battelle Memorial Institute Processes for delivery of viscous drug therapies
PL2849723T3 (pl) 2012-05-18 2018-10-31 Genentech, Inc. Formulacje o wysokim stężeniu przeciwciał monoklonalnych
WO2014151705A1 (en) * 2013-03-15 2014-09-25 Ansun Biopharma, Inc. Methods for preparing injectable protein microparticle suspensions
IL312865B2 (en) 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
CN103976947B (zh) * 2014-06-05 2016-08-17 段明星 一种含酶油悬浮剂及其制备方法与应用
SG11201702614SA (en) 2014-10-01 2017-04-27 Eagle Biolog Inc Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
JP5774190B1 (ja) * 2014-12-12 2015-09-09 ジーンメディカル株式会社 皮下注射用剤及び皮下注射用剤を含有する注射器の製造方法
BR112017012289B1 (pt) * 2014-12-12 2022-11-16 Motejo. Ltd Agente para injeção hipodérmica
WO2018067987A1 (en) * 2016-10-06 2018-04-12 Amgen Inc. Reduced viscosity protein pharmaceutical formulations
AU2017364077A1 (en) 2016-11-22 2019-06-20 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
WO2019023392A1 (en) 2017-07-25 2019-01-31 Elektrofi, Inc. FORMATION OF PARTICLES COMPRISING AGENTS
US12115262B2 (en) 2018-05-24 2024-10-15 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
KR102051808B1 (ko) 2018-07-23 2019-12-04 주식회사 종근당 테스토스테론 운데카노에이트를 포함하는 안정한 약제학적 조성물
CN113365609A (zh) 2019-01-31 2021-09-07 伊勒卓菲公司 颗粒形成和形态
AU2020219125B2 (en) 2019-02-05 2025-10-02 Lindy Biosciences, Inc. Isolated cell culture components and methods for isolating the same from liquid cell culture medium
US20200376128A1 (en) * 2019-06-01 2020-12-03 Lupin Holdings B.V. Monodisperse resorbable polyester polymer compositions, systems, and methods
WO2021050953A1 (en) * 2019-09-13 2021-03-18 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
US12377050B2 (en) 2020-04-17 2025-08-05 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795516A (fr) 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
US4310516A (en) 1980-02-01 1982-01-12 Block Drug Company Inc. Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
EP0079143A3 (en) 1981-10-20 1984-11-21 Adnovum Ag Pseudoplastic gel transfer
US4594108A (en) 1983-09-19 1986-06-10 The Dow Chemical Company Highly pseudoplastic polymer solutions
US5411951A (en) 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
US5288479A (en) 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
SE465950B (sv) 1989-10-23 1991-11-25 Medinvent Sa Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
US5300302A (en) 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
YU87892A (sh) 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
ZA932272B (en) 1992-03-30 1993-10-19 Alza Corp Viscous suspensions of controlled-release drug particles
AU3941793A (en) 1992-03-30 1993-11-08 Alza Corporation Additives for bioerodible polymers to regulate degradation
US5512293A (en) 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
SE9203594D0 (sv) 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
CA2185119C (en) 1994-06-13 2005-07-26 Steven D. Larsen Dosage form for administering drug in liquid formulation
US5904935A (en) 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US5932547A (en) 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5916582A (en) 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
CZ433898A3 (cs) 1996-07-03 1999-04-14 Alza Corporation Nevodné protické peptidové formulace
IN184589B (OSRAM) 1996-10-16 2000-09-09 Alza Corp
US7393630B2 (en) * 1997-12-16 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Use of microparticles combined with submicron oil-in-water emulsions
KR20080045300A (ko) 1999-02-08 2008-05-22 알자 코포레이션 안정한 비수성 단일상 점성 비히클 및 그 비히클을이용하는 제형물
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
FR2809309B1 (fr) * 2000-05-23 2004-06-11 Mainelab Microspheres a liberation prolongee pour administration injectable
WO2002043580A2 (en) 2000-10-27 2002-06-06 Epic Therapeutics, Inc. Production of microspheres
US20040022861A1 (en) * 2001-01-30 2004-02-05 Williams Robert O. Process for production of nanoparticles and microparticles by spray freezing into liquid
DE60231862D1 (de) * 2001-02-23 2009-05-20 Genentech Inc Erodierbare polymere zur injektion
NZ530700A (en) * 2001-06-21 2009-02-28 Altus Pharmaceuticals Inc Spherical protein particles and methods of making and using them
WO2004060343A1 (en) 2002-12-31 2004-07-22 Nektar Therapeutics Antibody-containing particles and compositions
AU2004229335C1 (en) * 2003-04-04 2010-06-17 Genentech, Inc. High concentration antibody and protein formulations
WO2004112747A2 (en) 2003-06-24 2004-12-29 Baxter International Inc. Specific delivery of drugs to the brain
WO2005035088A2 (en) 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical by controlled phase separation
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
EP1753404A1 (en) 2004-05-12 2007-02-21 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US20060141040A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2006083761A2 (en) * 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US20070015689A1 (en) 2005-06-23 2007-01-18 Alza Corporation Complexation of metal ions with polypeptides
WO2007076295A2 (en) 2005-12-16 2007-07-05 University Of Kansas Nanoclusters for delivery of therapeutics
JP5147699B2 (ja) 2005-12-20 2013-02-20 富士フイルム株式会社 タンパク質ナノ粒子およびその使用
US20080102128A1 (en) * 2006-07-28 2008-05-01 Flamel Technologies, Inc. Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
CA2691531C (en) * 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
CN101081882A (zh) * 2007-07-06 2007-12-05 天津大学 大分子印迹交联聚乙烯基吡咯烷酮微球及低温悬浮聚合制备方法
JP2009173610A (ja) 2008-01-28 2009-08-06 Fujifilm Corp タンパク質ナノ粒子
CN101965195A (zh) 2008-03-05 2011-02-02 巴克斯特国际公司 用于药物投送的组合物和方法
KR101616771B1 (ko) 2008-05-09 2016-04-29 사우스다코타주립대학 비면역원성의 소수성 단백질 나노입자의 형성방법 및 그 용도
US20100009007A1 (en) 2008-07-10 2010-01-14 Baxter International Inc. Non-covalent modification of microparticles and process of preparing same
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
AR075715A1 (es) 2009-03-05 2011-04-20 Novartis Ag Formulacion de anticuerpo liofilizado

Similar Documents

Publication Publication Date Title
IL274398A (en) ANTI-IGF-1R antibodies that eliminate binding to FCRN and their use in the treatment of vascular diseases of the eye
AR099912A1 (es) Derivados de exendina-4 como agonistas dobles de glp1 / gip o triples de glp1 / gip / glucagon
MX2016015997A (es) Preparacion y uso de beta-d-nicotinamida ribosido cristalina.
IL285440A (en) Oral compositions containing octreotide in combination with other therapeutic agents for tretment of acromegaly
TWD190432S (zh) 鼻管
MX2016014414A (es) Vacuna de peptido que comprende un peptido ras mutante y un agente quimioterapeutico.
MX2016014622A (es) Sistemas de suministro de medicamentos y metodos de uso relacionados.
MX381016B (es) Composiciones de nanopartículas para su uso en la entrega de una carga útil al cerebro.
JP2016540026A5 (OSRAM)
JP2016540030A5 (OSRAM)
BR112016016932A8 (pt) uso de uma combinação de oxaliplatina (oxa), leucovorina (lv) e 5-fluorouracil (5-fu)
EP3037877A3 (en) A pellicle
TWD174176S (zh) 給藥裝置之部分（二）
ES2700448R1 (es) Uso de ligandos del receptor sigma en la diabetes y el sindrome metabolico
Uski Postfeminism through magic realism in Angela Carter's The Passion of New Eve
RU2014151103A (ru) Применение соединений класса 1,3,4-тиадиазина и их фармацевтической композиции с аскорбиновой кислотой в качестве средства коррекции экспериментального аллоксанового сахарного диабета
Yan Mobile Internet Era’s Explosive Growth in Full Swing
CN302510909S (zh) 燃油喷射泵(cb6p990)
CN302487912S (zh) 包装瓶
CN302586572S (zh) 无针注射器
CN302570718S (zh) 医用敷料
吴一凡 My Chinese Teacher
CN302383700S (zh) 笔
TWD168875S (zh) 吊燈
CN302488528S (zh) 轨压传感器